Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
18.65
-0.26 (-1.37%)
At close: Apr 29, 2025, 3:59 PM
17.91
-3.97%
Pre-market: Apr 30, 2025, 04:07 AM EDT
Enliven Therapeutics Revenue
Enliven Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Enliven Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
62
Market Cap
913.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |